Nathan Rich
Stock Analyst at Goldman Sachs
(0.80)
# 3,675
Out of 5,182 analysts
85
Total ratings
34.92%
Success rate
-10.29%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HUM Humana | Maintains: Sell | $215 → $158 | $223.62 | -29.34% | 8 | Feb 17, 2026 | |
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $17.18 | +22.24% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $117.87 | +66.28% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $11.96 | +150.84% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $12.57 | -36.36% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $26.77 | -34.63% | 4 | May 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $22.09 | -36.62% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $31.26 | -64.81% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $184.70 | +21.82% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $574.95 | +13.05% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $78.36 | +12.30% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $20.95 | -42.72% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $77.20 | +10.10% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $14.81 | -25.73% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $179.22 | +86.92% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $354.69 | +50.84% | 5 | Dec 14, 2021 |
Humana
Feb 17, 2026
Maintains: Sell
Price Target: $215 → $158
Current: $223.62
Upside: -29.34%
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $17.18
Upside: +22.24%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $117.87
Upside: +66.28%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $11.96
Upside: +150.84%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $12.57
Upside: -36.36%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $26.77
Upside: -34.63%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $22.09
Upside: -36.62%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $31.26
Upside: -64.81%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $184.70
Upside: +21.82%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $574.95
Upside: +13.05%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $78.36
Upside: +12.30%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $20.95
Upside: -42.72%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $77.20
Upside: +10.10%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $14.81
Upside: -25.73%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $179.22
Upside: +86.92%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $354.69
Upside: +50.84%